These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9801427)

  • 21. Transdermal iontophoresis of insulin. II. Physicochemical considerations.
    Pillai O; Borkute SD; Sivaprasad N; Panchagnula R
    Int J Pharm; 2003 Mar; 254(2):271-80. PubMed ID: 12623203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous absorption of salicylic acid--in vitro and in vivo studies.
    Mateus R; Moore DJ; Hadgraft J; Lane ME
    Int J Pharm; 2014 Nov; 475(1-2):471-4. PubMed ID: 25178827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On mathematical modeling of dermal and transdermal drug delivery.
    Manitz R; Lucht W; Strehmel K; Weiner R; Neubert R
    J Pharm Sci; 1998 Jul; 87(7):873-9. PubMed ID: 9649357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transdermal delivery of ketorolac tromethamine: permeation enhancement, device design, and pharmacokinetics in healthy humans.
    Roy SD; Manoukian E
    J Pharm Sci; 1995 Oct; 84(10):1190-6. PubMed ID: 8801333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Göttingen minipig skin for transdermal in vitro permeation studies.
    Qvist MH; Hoeck U; Kreilgaard B; Madsen F; Frokjaer S
    Eur J Pharm Sci; 2000 Jul; 11(1):59-68. PubMed ID: 10913754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Release characteristics of anionic drug compounds from liquid crystalline gels. Part II. The effects of ion pairing and buffering on the passive delivery of anionic drugs across non-rate-limiting membranes.
    Fitzpatrick D; Corish J
    Int J Pharm; 2006 Mar; 311(1-2):139-46. PubMed ID: 16426777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of emulsifiers and their liquid crystalline structures in emulsions on dermal and transdermal delivery of hydroquinone, salicylic acid and octadecenedioic acid.
    Otto A; Wiechers JW; Kelly CL; Dederen JC; Hadgraft J; du Plessis J
    Skin Pharmacol Physiol; 2010; 23(5):273-82. PubMed ID: 20484969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A mixture theory for charged-hydrated soft tissues containing multi-electrolytes: passive transport and swelling behaviors.
    Gu WY; Lai WM; Mow VC
    J Biomech Eng; 1998 Apr; 120(2):169-80. PubMed ID: 10412377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of some natural compounds on the transdermal absorption and penetration of caffeine and salicylic acid.
    Muhammad F; Riviere JE
    Int J Pharm; 2015 Apr; 483(1-2):151-7. PubMed ID: 25681718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pretreatment effects of moxibustion on the skin permeation and skin and muscle concentrations of salicylate in rats.
    Cao D; Tazawa Y; Ishii H; Todo H; Sugibayashi K
    Int J Pharm; 2011 Apr; 407(1-2):105-10. PubMed ID: 21256938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of sucrose fatty acid esters in transdermal therapeutic systems.
    Csóka G; Marton S; Zelko R; Otomo N; Antal I
    Eur J Pharm Biopharm; 2007 Feb; 65(2):233-7. PubMed ID: 16963242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative study on transdermal osmosis in vitro of Aconitum brachypodium liniment, gel and patcher].
    Lin YP; Zhao Y; Zhang YP; Liang GY
    Zhongguo Zhong Yao Za Zhi; 2007 Feb; 32(3):203-6. PubMed ID: 17432138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controlled transdermal iontophoresis by ion-exchange fiber.
    Jaskari T; Vuorio M; Kontturi K; Urtti A; Manzanares JA; Hirvonen J
    J Control Release; 2000 Jul; 67(2-3):179-90. PubMed ID: 10825552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ionisation and the effect of absorption enhancers on transport of salicylic acid through silastic rubber and human skin.
    Smith JC; Irwin WJ
    Int J Pharm; 2000 Dec; 210(1-2):69-82. PubMed ID: 11163989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of lipophilicity on microneedle-mediated iontophoretic transdermal delivery across human skin in vitro.
    Pawar KR; Smith F; Kolli CS; Babu RJ
    J Pharm Sci; 2013 Oct; 102(10):3784-91. PubMed ID: 23955316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of asymmetric donor-receiver ion concentration upon transscleral iontophoretic transport.
    Li SK; Zhang Y; Zhu H; Higuchi WI; White HS
    J Pharm Sci; 2005 Apr; 94(4):847-60. PubMed ID: 15736190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro permeation of carvedilol through porcine skin: effect of vehicles and penetration enhancers.
    Gannu R; Vishnu YV; Kishan V; Rao YM
    PDA J Pharm Sci Technol; 2008; 62(4):256-63. PubMed ID: 19174954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transport mechanisms in iontophoresis. III. An experimental study of the contributions of electroosmotic flow and permeability change in transport of low and high molecular weight solutes.
    Pikal MJ; Shah S
    Pharm Res; 1990 Mar; 7(3):222-9. PubMed ID: 2339093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo microdialysis for the investigation of drug levels in the dermis and the effect of barrier perturbation on cutaneous drug penetration. Studies in hairless rats and human subjects.
    Benfeldt E
    Acta Derm Venereol Suppl (Stockh); 1999; 206():1-59. PubMed ID: 10605601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and in vitro evaluation of pressure sensitive adhesive patch for the transdermal delivery of galantamine: Effect of penetration enhancers and crystallization inhibition.
    Ameen D; Michniak-Kohn B
    Eur J Pharm Biopharm; 2019 Jun; 139():262-271. PubMed ID: 30981946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.